$1.42 -0.05 (%) Sunesis Pharmaceuticals Inc - NASDAQ

Oct. 22, 2014 | 04:00 PM

Partner Headlines

  1. Sunesis Pharmaceuticals, Inc.'s Flop: More Drugs Out There, Says Roth

    Benzinga | Oct. 7, 2014 | 16:19PM EST
  2. U.S. Stocks Turn Red; CareFusion Shares Surge On Announcement Of Acquisition By Becton, Dickinson

    Benzinga | Oct. 6, 2014 | 14:00PM EST
  3. Markets Open Higher; Hewlett-Packard Plans To Split Into Two Companies

    Benzinga | Oct. 6, 2014 | 10:58AM EST
  4. Stocks Hitting 52-Week Lows

    Benzinga | Oct. 6, 2014 | 10:20AM EST
  5. Benzinga's Top #PreMarket Losers

    Benzinga | Oct. 6, 2014 | 08:08AM EST
  6. Morning Market Losers

    Benzinga | Aug. 29, 2014 | 09:52AM EST
  7. Benzinga's Top Downgrades

    Benzinga | Aug. 29, 2014 | 09:15AM EST
  8. Wedbush Downgrades Sunesis Pharmaceuticals To Neutral, Shares Drop

    Benzinga | Aug. 29, 2014 | 08:31AM EST
  9. UBS Says Sunesis Leukemia Pivotal Trial Success 'Likely'

    Benzinga | Aug. 27, 2014 | 16:05PM EST
  10. Sunesis Pharmaceuticals Announces European Medicines Agency Acceptance of Pediatric Investigation Plan for Qinprezo For AML

    Benzinga | Jul. 9, 2014 | 07:04AM EST
  11. Events Scheduled for Week of Jun. 16th to Jun. 20th

    Benzinga | Jun. 17, 2014 | 10:48AM EST
  12. Sunesis Announces Data of Ongoing Vosaroxin Study at ASCO

    Benzinga | Apr. 22, 2014 | 07:09AM EST
  13. Mid-Morning Market Update: Markets Drop; Family Dollar Plans To Close 370 Stores

    Benzinga | Apr. 10, 2014 | 10:27AM EST
  14. Sunesis Pharmaceuticals Announces Global Licenses for Two Kinase Inhibitor Programs

    Benzinga | Jan. 9, 2014 | 07:06AM EST
  15. Sunesis Pharmaceuticals Announces Investigator-Sponsored Phase I/II Trial Evaluating Vosaroxin in Myelodysplastic Syndrome

    Benzinga | Oct. 28, 2013 | 07:07AM EST
  16. Sunesis Pharmaceuticals Announces Closing of $40 Million in Previously Announced Royalty and Debt Financings

    Benzinga | Sep. 20, 2012 | 01:04AM EST
  17. Stocks Hitting 52-Week Highs

    Benzinga | Sep. 11, 2012 | 04:03AM EST
  18. Morning Market Movers

    Benzinga | Sep. 11, 2012 | 03:48AM EST
  19. From Earlier: Sunesis Pharmaceuticals to Implement One-Time Sample Size Increase to Phase 3 VALOR Trial in AML

    Benzinga | Sep. 11, 2012 | 02:21AM EST
  20. Cantor Fitzgerald Reiterates Buy Rating, $6 PT for Sunesis Pharmaceuticals

    Benzinga | Jun. 15, 2012 | 04:42AM EST
  21. Benzinga's Microcap Movers for Monday March 5, 2012

    Benzinga | Mar. 5, 2012 | 15:18PM EST
Trading Center